Figure 2.
![Figure 2. hMSCs convert activating APCs into T-cell inhibitors. Either CD4+ T cells (A,C) or CD8+ T cells (B) were stimulated with SEB (1 ng/mL) in the absence (□) or presence (▪) of hMSCs (5 × 104 cells) and increasing numbers of either monocytes (A,B) or DCs (C). T-cell activation was followed by either IFN-γ secretion, incorporation of [3H]thymidine, or IL-5 secretion to the media. Each panel shows 1 representative experiment of 3.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/105/5/10.1182_blood-2004-07-2921/6/zh80050574820002.jpeg?Expires=1722785525&Signature=SEatfNOukf1~Q5CbkNVm4xxw746jjYlcZmcIq6x7lVO3WiVCZ9oELyXigq~zMjYGN5t12L0xcSXq5Hr6wjJyTVVAC3g~scg9HOQTyT1gHI9UBqOujC6qn38593ocqbvbCDuiRFeqUMrp88Ax5fEcdtTN2-BIrwTuGDHhB7mk99fARI8HYW7Z38KS3nsFOYB3KJTStZnzGkWRM-6ThlgTps29qMpqiL0eL02wehUnNk6Oz-9wT89EIFAFuCPuff5755s4FDNehppgPVJyFSaseAGCAaEMNk6TVz5TlthiC6TY72GMqHdxduQhE3Cqx6DneZzuSnFv39JPaaTT~EmbNw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
hMSCs convert activating APCs into T-cell inhibitors. Either CD4+ T cells (A,C) or CD8+ T cells (B) were stimulated with SEB (1 ng/mL) in the absence (□) or presence (▪) of hMSCs (5 × 104 cells) and increasing numbers of either monocytes (A,B) or DCs (C). T-cell activation was followed by either IFN-γ secretion, incorporation of [3H]thymidine, or IL-5 secretion to the media. Each panel shows 1 representative experiment of 3.
